This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Epilepsies, Partial
and you are
between 16 and 75
years old
The phase for this study is not defined.
Show me locations

The purpose

The investigators will treat patients with fully characterized refractory unifocal neocortical epilepsy with a technique that delivers magnetic waves (transcranial magnetic stimulation, TMS) to the region that causes the epilepsy. Active rTMS applied over the epileptogenic focus will reduce seizure frequency compared with sham rTMS.

Provided treatments

  • Device: figure-of-eight active rTMS coil
  • Device: round active rTMS coil
  • Device: sham rTMS coil (figure-of-eight)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01745952. The sponsor of the trial is Universitaire Ziekenhuizen Leuven and it is looking for 11 volunteers for the current phase.
Official trial title:
Multimodal Image-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Refractory Partial Epilepsy.